Literature DB >> 30586140

Buprenorphine Deregulation and Mainstreaming Treatment for Opioid Use Disorder: X the X Waiver.

Kevin Fiscella1, Sarah E Wakeman2, Leo Beletsky3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30586140     DOI： 10.1001/jamapsychiatry.2018.3685

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN： 2168-622X            Impact factor:   21.596


× No keyword cloud information.
  43 in total

1.  Infectious Complications of Addiction: A Call for a New Subspecialty Within Infectious Diseases.

Authors:  David P Serota; Joshua A Barocas; Sandra A Springer
Journal:  Clin Infect Dis       Date:  2020-02-14       Impact factor: 9.079

2.  ACMT Position Statement: Remove the Waiver Requirement for Prescribing Buprenorphine for Opioid Use Disorder.

Authors:  Ryan Marino; Jeanmarie Perrone; Lewis S Nelson; Timothy J Wiegand; Evan S Schwarz; Paul M Wax; Andrew I Stolbach
Journal:  J Med Toxicol       Date:  2019-08-14

3.  The effect of Medicaid expansion on use of opioid agonist treatment and the role of provider capacity constraints.

Authors:  Alex K Gertner; Allison G Robertson; Hendree Jones; Byron J Powell; Pam Silberman; Marisa E Domino
Journal:  Health Serv Res       Date:  2020-03-12       Impact factor: 3.402

4.  The Broken Care Continuum for Young Adults With Opioid Addiction.

Authors:  Scott E Hadland
Journal:  J Adolesc Health       Date:  2020-12       Impact factor: 5.012

5.  Federal Barriers to Addressing the Opioid Epidemic.

Authors:  Robert A Kleinman; Nathaniel P Morris
Journal:  J Gen Intern Med       Date:  2020-02-19       Impact factor: 5.128

6.  Offering Emergency Buprenorphine Without a Prescription.

Authors:  Payel Jhoom Roy; Michael D Stein
Journal:  JAMA       Date:  2019-07-08       Impact factor: 56.272

7.  A systematic review of patients' and providers' perspectives of medications for treatment of opioid use disorder.

Authors:  Katharine Cioe; Breanne E Biondi; Rebecca Easly; Amanda Simard; Xiao Zheng; Sandra A Springer
Journal:  J Subst Abuse Treat       Date:  2020-09-22

8.  Responding to the opioid and overdose crisis with innovative services: The recovery community center office-based opioid treatment (RCC-OBOT) model.

Authors:  Robert D Ashford; Austin M Brown; Jessica McDaniel; Jenna Neasbitt; Chad Sobora; Robert Riley; Lesley Weinstein; Aaron Laxton; Justin Kunzelman; Kyle Kampman; Brenda Curtis
Journal:  Addict Behav       Date:  2019-06-21       Impact factor: 3.913

9.  Opioid Agonist Therapy During Hospitalization Within the Veterans Health Administration: a Pragmatic Retrospective Cohort Analysis.

Authors:  Kelsey C Priest; Travis I Lovejoy; Honora Englander; Sarah Shull; Dennis McCarty
Journal:  J Gen Intern Med       Date:  2020-04-14       Impact factor: 5.128

10.  Integrating Responses to the Opioid Use Disorder and Infectious Disease Epidemics: A Report From the National Academies of Sciences, Engineering, and Medicine.

Authors:  Sandra A Springer; Andrew P Merluzzi; Carlos Del Rio
Journal:  JAMA       Date:  2020-07-07       Impact factor: 56.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.